No connection

Search Results

NHS

NEUTRAL
$6.46 Live
Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc. · AMEX
$6.27 52W Range $7.8

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated May 01, 2026
Market cap
$202.79M
P/E
9.79
ROE
8.6%
Profit margin
86.8%
Debt/Equity
0.43
Dividend yield
16.81%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
NHS presents a classic 'yield trap' scenario, characterized by a stable Piotroski F-Score of 5/9 but a critically unsustainable dividend payout ratio of 164.55%. While the stock is significantly undervalued relative to its Graham Number ($10.51) and Intrinsic Value ($10.26), the market is pricing in the risk of a dividend cut and a completely bearish technical trend (0/100). The fund maintains a stable financial health profile with low debt/equity, but the disconnect between earnings and distributions is a primary concern.

Key Strengths

Significant discount to Graham Number and Intrinsic Value
Strong profit margins (86.82%) and operating margins (88.53%)
Low Debt/Equity ratio (0.43) compared to sector average (1.28)
Price-to-Book ratio below 1.0 (0.87), suggesting asset undervaluation
Stable Piotroski F-Score (5/9) indicating consistent financial health

Key Risks

Unsustainable payout ratio (164.55%) indicating capital erosion
Severe bearish technical trend (0/100)
Low dividend strength score (40/100) despite high nominal yield
Modest revenue and earnings growth (6.7% and 5.7% respectively)
Lack of analyst coverage and insider buying activity
AI Fair Value Estimate
Based on comprehensive analysis
$10.38
+60.7% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
52
Moderate
Value
88
Future
40
Past
50
Health
60
Dividend
20
AI Verdict
Value Trap / Income Risk
Key drivers: Extreme dividend payout ratio, Deep discount to intrinsic value, Bearish price action
Confidence
90%
Value
88/100

Ref P/E, PEG, Graham Number

Positives
  • Price $6.46 is well below Graham Number $10.51
  • P/E of 9.79 is low compared to sector average
Watchpoints
  • Market continues to discount the asset
Future
40/100

Ref Growth rates

Positives
  • Positive YoY revenue and earnings growth
Watchpoints
  • Dividend is not covered by earnings
  • Technical trend is 0/100
Past
50/100

Ref Historical trends

Positives
  • Positive 3Y change (+10.4%)
Watchpoints
  • Negative 1Y (-2.6%) and 6M (-7.1%) performance
Health
60/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Piotroski F-Score 5/9 (Stable)
  • Low Debt/Equity (0.43)
Watchpoints
  • Altman Z-Score not available
  • Current ratio (1.12) is tight
Dividend
20/100

Ref Yield, Payout

Positives
  • Very high nominal yield (16.81%)
Watchpoints
  • Payout ratio of 164.55% is fundamentally unsustainable

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$6.46

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for NHS and closest competitors.

Updated 2026-04-30
NHS
Neuberger Berman Income Funds - Neuberger High Yield Strategies Fund Inc.
Primary
5Y
-4.8%
3Y
+10.4%
1Y
-2.6%
6M
-7.1%
1M
+1.1%
1W
+0.9%
CMT
Community Bancorp
Peer
5Y
+130.5%
3Y
+116.2%
1Y
+119.1%
6M
+63.4%
1M
+15.3%
1W
+16.1%
FT
Franklin Universal Trust
Peer
5Y
+52.1%
3Y
+46.6%
1Y
+19.0%
6M
+5.1%
1M
+2.2%
1W
-1.8%
ETX
Eaton Vance Municipal Income 2028 Term Trust
Peer
5Y
+6.3%
3Y
+17.3%
1Y
+9.6%
6M
+0.4%
1M
+0.4%
1W
+1.2%
PMT
CPI Card Group Inc.
Peer
5Y
+9.1%
3Y
-59.3%
1Y
-28.2%
6M
+17.1%
1M
+23.8%
1W
+5.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
9.79
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
0.87
P/S Ratio
8.71
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$202.79M

Profitability

Profit margins and return metrics

Profit Margin 86.82%
Operating Margin 88.53%
Gross Margin 100.0%
ROE 8.65%
ROA 3.88%

Growth

Revenue and earnings growth rates

Revenue Growth +6.7%
Earnings Growth +5.7%
Q/Q Revenue Growth N/A
Q/Q Earnings Growth +11.3%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.43
Low debt
Current Ratio
1.12
Good
Quick Ratio
1.05
Good
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Total Assets
$0.3B
Liabilities
$0.1B
Equity
$0.2B
Debt/Equity
0.46x

Financial Services Sector Comparison

Comparing NHS against 956 companies in the Financial Services sector (153 bullish, 417 neutral, 386 bearish)
P/E Ratio
9.79
This Stock
vs
35.14
Sector Avg
-72.1% (Discount)
Return on Equity (ROE)
8.65%
This Stock
vs
0.3%
Sector Avg
+2764.2% (Excellent)
Profit Margin
86.82%
This Stock
vs
89.71%
Sector Avg
-3.2% (Weaker)
Debt to Equity
0.43
This Stock
vs
1.28
Sector Avg
-66.1% (Less Debt)
Revenue Growth
6.7%
This Stock
vs
33.39%
Sector Avg
-79.9% (Slower)
Current Ratio
1.12
This Stock
vs
2.99
Sector Avg
-62.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

LIND JOSEPH W.
Other Executive
Stock Award
2026-04-15
12,833 shares
KOCINSKI CHRISTOPHER J.
Other Executive
Option Exercise
2026-04-15
7,000 shares · $45,500
Insider transactions can signal confidence or concerns about company prospects

Past News Coverage

Recent headlines mentioning NHS from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile